<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01395381</url>
  </required_header>
  <id_info>
    <org_study_id>MJM-albendazole</org_study_id>
    <nct_id>NCT01395381</nct_id>
  </id_info>
  <brief_title>Effectiveness of Oral Albendazole in the Treatment of Severe Acute Malnutrition</brief_title>
  <official_title>Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Benefit of Antihelminthic Therapy in the Community-Based Treatment of Severe Acute Malnutrition in Malawian Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Malawi College of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Washington University School of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The benefit of anti-worm therapy as part of the case management of severe acute malnutrition
      (SAM) in the outpatient setting has not previously been studied. This study will compare
      recovery rates of children with SAM treated in the community with locally-produced
      ready-to-use therapeutic food (RUTF) with and without prescribed albendazole as part of their
      case management.
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    not funded
  </why_stopped>
  <start_date>January 2013</start_date>
  <primary_completion_date type="Anticipated">January 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>nutritional recovery</measure>
    <time_frame>12 weeks</time_frame>
    <description>Weight-for-Height Z-score (WHZ) &gt; -2 without bipedal pitting edema</description>
  </primary_outcome>
  <primary_outcome>
    <measure>mortality</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>malnutrition relapse</measure>
    <time_frame>6 months</time_frame>
    <description>acute malnutrition, either moderate (WHZ &lt; -2) or severe (WHZ &lt; -3 and/or bipedal pitting edema)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>height and weight gain</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Kwashiorkor</condition>
  <condition>Marasmus</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Albendazole</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>placebo given once</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Albendazole</intervention_name>
    <description>single dose albendazole given at the time of enrollment</description>
    <arm_group_label>Albendazole</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  12-59 months old

          -  Kwashiorkor and/or Marasmus

          -  Qualified for home-based therapeutic feeding with RUTF

        Exclusion Criteria:

          -  Obvious congenital or other malformation that makes child a poor candidate for feeding
             with RUTF

          -  Unable to consume test-dose of RUTF in clinic

          -  Parent refusal to participate and return for follow-up
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>59 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mark J Manary, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Malawi</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kenneth Maleta, MBBS PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Malawi</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Indi Trehan, MD MPH DTM&amp;H</last_name>
    <role>Study Director</role>
    <affiliation>University of Malawi</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>St. Louis Nutrition Project</name>
      <address>
        <city>Blantyre</city>
        <country>Malawi</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Malawi</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 1, 2011</study_first_submitted>
  <study_first_submitted_qc>July 13, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 15, 2011</study_first_posted>
  <last_update_submitted>January 24, 2014</last_update_submitted>
  <last_update_submitted_qc>January 24, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 28, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Malnutrition</mesh_term>
    <mesh_term>Severe Acute Malnutrition</mesh_term>
    <mesh_term>Kwashiorkor</mesh_term>
    <mesh_term>Protein-Energy Malnutrition</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Albendazole</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

